Makriyannis A - Search Results

1

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.

Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG. Ross RA, et al. Among authors: makriyannis a. Br J Pharmacol. 1999 Feb;126(3):665-72. doi: 10.1038/sj.bjp.0702351. Br J Pharmacol. 1999. PMID: 10188977 Free PMC article.

2

AM630, a competitive cannabinoid receptor antagonist.

Pertwee R, Griffin G, Fernando S, Li X, Hill A, Makriyannis A. Pertwee R, et al. Among authors: makriyannis a. Life Sci. 1995;56(23-24):1949-55. doi: 10.1016/0024-3205(95)00175-6. Life Sci. 1995. PMID: 7776818

3

Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations.

Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A. Pertwee RG, et al. Among authors: makriyannis a. Eur J Pharmacol. 1995 Jan 5;272(1):73-8. doi: 10.1016/0014-2999(94)00618-h. Eur J Pharmacol. 1995. PMID: 7713152

4

Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).

Kulkarni PM, Kulkarni AR, Korde A, Tichkule RB, Laprairie RB, Denovan-Wright EM, Zhou H, Janero DR, Zvonok N, Makriyannis A, Cascio MG, Pertwee RG, Thakur GA. Kulkarni PM, et al. Among authors: makriyannis a. J Med Chem. 2016 Jan 14;59(1):44-60. doi: 10.1021/acs.jmedchem.5b01303. Epub 2015 Nov 28. J Med Chem. 2016. PMID: 26529344 Free PMC article.

5

Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand.

Lan R, Gatley J, Lu Q, Fan P, Fernando SR, Volkow ND, Pertwee R, Makriyannis A. Lan R, et al. Among authors: makriyannis a. AAPS PharmSci. 1999;1(2):E4. doi: 10.1208/ps010204. AAPS PharmSci. 1999. PMID: 11741201 Free PMC article.

6

Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists.

Lan R, Liu Q, Fan P, Lin S, Fernando SR, McCallion D, Pertwee R, Makriyannis A. Lan R, et al. Among authors: makriyannis a. J Med Chem. 1999 Feb 25;42(4):769-76. doi: 10.1021/jm980363y. J Med Chem. 1999. PMID: 10052983

7

In vitro determination of the efficacy of illicit synthetic cannabinoids at CB₁ receptors.

Sachdev S, Vemuri K, Banister SD, Longworth M, Kassiou M, Santiago M, Makriyannis A, Connor M. Sachdev S, et al. Among authors: makriyannis a. Br J Pharmacol. 2019 Dec;176(24):4653-4665. doi: 10.1111/bph.14829. Epub 2019 Dec 10. Br J Pharmacol. 2019. PMID: 31412133 Free PMC article.

8

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriyannis A. Abadji V, et al. Among authors: makriyannis a. J Med Chem. 1994 Jun 10;37(12):1889-93. doi: 10.1021/jm00038a020. J Med Chem. 1994. PMID: 8021930

9

Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.

Papahatjis DP, Nikas SP, Kourouli T, Chari R, Xu W, Pertwee RG, Makriyannis A. Papahatjis DP, et al. Among authors: makriyannis a. J Med Chem. 2003 Jul 17;46(15):3221-9. doi: 10.1021/jm020558c. J Med Chem. 2003. PMID: 12852753

10

Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism.

Krylatov AV, Uzhachenko RV, Maslov LN, Bernatskaya NA, Makriyannis A, Mechoulam R, Pertwee RG, Sal'nikova OM, Stefano JB, Lishmanov Y. Krylatov AV, et al. Among authors: makriyannis a. Bull Exp Biol Med. 2002 Feb;133(2):122-4. doi: 10.1023/a:1015574100494. Bull Exp Biol Med. 2002. PMID: 12428277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

520 results

Search Page

Filters